Work

Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasm

Year: 2019

Type: article

Source: Expert Review of Clinical Pharmacology

DOI: 10.1080/17512433.2019.1662297

Authors: Minas P. Economides, Deborah McCue, Andrew A. Lane, Naveen Pemmaraju

Institutions: The University of Texas Health Science Center at Houston, The University of Texas MD Anderson Cancer Center, Dana-Farber Cancer Institute

Language: English

Topic: Toxin Mechanisms and Immunotoxins

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: European Hematology Association

Award: G1453247788

OpenAlex ID: W2970664418

FWCI: 1.285

Cites: 57

Cited by: 22

Related to: 10